FDA.reportPublic FDA data

methylphenidate hydrochloride 5 MG/ML 24 HR Extended Release Suspension

RxCUI
1312583
RxNorm name
methylphenidate hydrochloride 5 MG/ML 24 HR Extended Release Suspension
Display name
methylphenidate hydrochloride 5 MG/ML 24 HR Extended Release Suspension
Full name
methylphenidate hydrochloride 5 MG/ML 24 HR Extended Release Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Quillivant XRMETHYLPHENIDATE HYDROCHLORIDENextWave Pharmaceuticals, Incc2dc2109-44a6-4797-b04e-18761dd9d45a2026-03-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1312583

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c2dc2109-44a6-4797-b04e-18761dd9d45amethylphenidate HCl 25 MG in 5 mL 24HR Extended Release Oral Suspension [PSN] · 24 HR methylphenidate hydrochloride 5 MG/ML Extended Release Suspension [SCD] · methylphenidate hydrochloride 25 MG per 5 ML 24 HR Extended Release Suspension [SY] · methylphenidate hydrochloride 5 MG/ML 24 HR Extended Release Suspension [SY]420These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 195520260320